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CLINICAL SCIENCE
Predicting dysthyroid optic neuropathy using com-
puted tomography volumetric analyses of orbital
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Ribeiro MonteiroI
I Faculdade de Medicina da Universidade de Sa˜o Paulo, Division of Ophthalmology, Sa˜o Paulo/SP, Brazil. II Faculdade de Medicina da Universidade de Sa˜o
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OBJECTIVE: To evaluate the ability of orbital apex crowding volume measurements calculated with multidetector-
computed tomography to detect dysthyroid optic neuropathy.
METHODS: Ninety-three patients with Graves’ orbitopathy were studied prospectively. All of the patients
underwent a complete neuro-ophthalmic examination and computed tomography scanning. Volumetric
measurements were calculated from axial and coronal contiguous sections using a dedicated workstation. Orbital
fat and muscle volume were estimated on the basis of their attenuation values (in Hounsfield units) using
measurements from the anterior orbital rim to the optic foramen. Two indexes of orbital muscle crowding were
calculated: i) the volumetric crowding index, which is the ratio between soft tissue (mainly extraocular muscles) and
orbital fat volume and is based on axial scans of the entire orbit; and ii) the volumetric orbital apex crowding index,
which is the ratio between the extraocular muscles and orbital fat volume and is based on coronal scans of the
orbital apex. Two groups of orbits (with and without dysthyroid optic neuropathy) were compared.
RESULTS: One hundred and two orbits of 61 patients with Graves’ orbitopathy met the inclusion criteria and were
analyzed. Forty-one orbits were diagnosed with Graves’ orbitopathy, and 61 orbits did not have optic neuropathy.
The two groups of orbits differed significantly with regard to both of the volumetric indexes (p,0.001). Although
both indexes had good discrimination ability, the volumetric orbital apex crowding index yielded the best results
with 92% sensitivity, 86% specificity, 81%/94% positive/negative predictive value and 88% accuracy at a cutoff of
4.14.
CONCLUSION: This study found that the orbital volumetric crowding index was a more effective predictor of
dysthyroid optic neuropathy than previously described computed tomography indexes were.
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INTRODUCTION
Graves’ orbitopathy (GO) is the most common extrathyr-
oid manifestation of Graves’ disease (GD). It occurs before,
during, or after the onset of hyperthyroidism and, less
frequently, in euthyroid or hypothyroid patients. The course
of GO can be divided into active (congestive) and inactive
(fibrotic) phases. Tissue expansion occurs within the
relatively fixed volume imposed by the bony orbit and
results in inflammation, the accumulation of hydrophilic
glycosaminoglycans and increased fat content (1). Clinical
signs include proptosis, congestive signs, strabismus, and
dysthyroid optic neuropathy (DON) (2-5).
DON is the most significant complication of GO. It affects
3.4 to 8% of GO patients (6-9) and requires prompt
treatment to avoid permanent visual loss. Almost all
instances of DON result from optic nerve compression at
the orbital apex by enlarged extraocular muscles. The
diagnosis of DON includes the following clinical features:
decreased visual acuity (VA), abnormal visual fields (VF),
impaired color and brightness perception, delayed visual
evoked potentials, afferent pupillary defects and edema or
atrophy of the optic nerve head (6). Unfortunately, some of
these tests require the full cooperation of an alert and
motivated patient and often render false positive results,
particularly in patients with congestive GO. Furthermore,
alternative causes of visual impairment secondary to GO,
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such as exposure keratopathy or secondary glaucoma, and
coincidental conditions, such as amblyopia or cataracts, may
also contribute to the considerable difficulty of detecting
DON (10). Because diagnosing DON can be clinically
difficult and because its prognosis improves significantly
with early diagnosis and treatment, it is important to design
objective tests that can identify patients at risk for develop-
ing DON (11).
Computed tomography (CT) is the most frequently used
imaging modality in patients with GO because of its
capacity to visualize bone and soft tissue in the orbit.
Previous studies have shown that a number of CT scan
parameters can help to detect and facilitate the diagnosis of
DON, primarily those parameters based on the detection of
orbital apical crowding by enlarged extraocular muscles (4-
6,12-16). Crowding has been successfully estimated with CT
parameters, such as linear measurements of extraocular
muscles (4,5,11,13), the subjective assessment of apical
crowding (on single coronal images) (4,11,16,17) and
measurements of the area (11) and volume (18,19) of the
orbital muscles.
Although linear and area measurements have proven to
be helpful in the diagnosis of DON, the assessment of orbital
apex crowding using volumetric estimates of structures
could potentially improve the ability to detect and diagnose
DON. In fact, Feldon et al. (2,18) used volumetric estimates
of orbital contents to investigate the risk of developing DON
in GO patients; however, those authors’ measurements
required cumbersome manual calculations of the orbital
muscles and other orbital structures. The recent introduc-
tion of multidetector-row computed tomography (MDCT)
has resulted in shorter scanning times and higher resolution
and has made it possible to reformat images from any plane,
making orbital measurements easier to take and more
precise. Using software for three-dimension orbital struc-
ture analysis, volumetric measurements can be easily
calculated at a workstation (20).
The purpose of this study was therefore to quantify
muscle crowding and use it to test the ability of two
volumetric indexes of muscle crowding based on volume
measurements obtained with multidetector-computed to-
mography to predict DON in the orbits of GO patients.
PATIENTS AND METHODS
The study followed the tenets of the Declaration of
Helsinki and was approved by an institutional ethics
committee. Ninety-three new patients with GO who were
admitted to the orbit service of a tertiary referral eye cen-
ter during the five-year study period were prospectively
included. GO was diagnosed in accordance with previously
established criteria (21). All of the patients underwent a
complete neuro-ophthalmic examination, including best-
corrected VA, applanation tonometry, pupillary reactions,
extraocular motility evaluation, slit lamp examination, soft
tissue and eyelid inflammation evaluation, lid fissure
measurement, Hertel exophthalmometry, fundoscopy, and
VF evaluation.
VF testing was performed using manual perimetry and
standard automated perimetry (SAP). Manual VF testing
was performed using the Goldmann perimeter (GP) (Haag-
Streit AG, Bern, Switzerland). SAP was performed with a
Humphrey Field Analyzer 750 (Zeiss-Humphrey, Dublin,
CA) using the 24-2 SITA-Standard strategy. The patients’
appropriate near correction was used. To qualify as an
abnormal VF on SAP, three adjacent abnormal points at the
p,0.05 level or two adjacent points with one abnormal point
at the p,0.01 level on the pattern deviation plot were required
(22). Exclusion criteria included the following: age under 20
years, inability to cooperate with VF testing, spherical
refraction over¡5 D, cylinder correction over¡3 D and
unreliable VF test results. An unreliable Humphrey VF test
was defined as one with more than 25% fixation losses, false-
positive or false-negative responses. Patients with clinical
signs of glaucomatous optic neuropathy, optic disc anomaly,
optic media opacities, previous orbital or strabismus surgery,
and other types of neuropathies were also excluded.
All patients were scanned with a 16-slice MDCT scanner
(Brilliance 16; Philips Medical Systems, Nederland B.V., The
Netherlands) without the use of sedation or intravenous
contrast. The CT scans were obtained using contiguous axial
slices, with the patient’s head positioned parallel to the
Frankfurt plane. The patients were instructed to keep their
eyes closed and steady in the primary gaze position. The
scanning parameters were as follows: 120 Kv, 200 mAs,
16x0.75 mm detector configuration, 1.5 mm slice thickness
and 0.7 mm slice increment. The images were postprocessed
at a dedicated workstation and read by a single head-and-
neck radiologist (L.N.S) who was blinded to the patients’
clinical condition.
Two volumetric indexes were calculated, one based on
axial scans of the entire orbit content (up to the orbital rim)
and one based on coronal scans of the orbital content from
the midpoint of the orbital segment of the optic nerve to the
orbital entrance of the optic canal.
Volume measurements of the entire orbit from
axial scans
To calculate volumes for the whole orbital content,
contiguous axial scans were analyzed. The different tissues
were color-coded according to their attenuation in
Hounsfield units (HU). Tissue HU thresholds were defined
using different window levels (WL) and window widths
(WW) to separate the soft tissue (which mainly includes
muscles, nerves and vessels) from other orbital tissues
(mainly fatty content). Orbital soft tissue thresholds were set
at 40/100 HU (WL/WW), and the fat tissue threshold was
set at -160/230 HU (WL/WW). For the tissue volume
measurements, each axial slice was traced along the bony
orbit limits. The anterior boundary of the orbit was
delineated by a straight line connecting the lateral and the
medial orbital rim (Figure 1). The marking began at the
topmost axial slice containing the orbit and continued
downwards, slice by slice, until all of the orbit content was
included. The volume of the muscles (including vessels and
nerves), soft tissues and fat within the marked space was
then estimated with the software (Figure 1). The volumetric
orbital muscle crowding index (VCI) was calculated as the
ratio between the soft tissue volume and the fat tissue
volume.
Volume measurements of the orbital apex from
coronal scans
One-millimeter coronal CT slabs were reformatted from
contiguous axial slices of the orbit, which includes the space
between the interzygomatic line and the orbital apex
(Figure 2). The orbital volume was calculated from the
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posterior portion of the orbit, which encompasses the tissues
within a point in the optic nerve halfway between the globe
and the orbital apex and up to the entrance of the optic
canal. The fat and soft tissues were color-coded with the
same settings used for the axial measurements. For each of
the preset coronal planes, a region of interest was traced
around the orbital bone rim (Figure 2). The software
automatically calculated the total volume of fat and soft
tissue in that region (Figure 2). The ratio of the soft tissue
volume to the fat volume (using volume measures taken at
the apex) was calculated to determine the volumetric orbital
apex crowding index (VACI).
The same reader repeated the measurements for 26
randomly selected orbits (13 with DON) approximately
eight months after the first measurements. On a different
occasion, the same group of orbits was independently
measured by a senior radiologist (E.M.M.S.G.). Both readers
were blinded to the presence or absence of DON.
GO patients’ eyes for which visual function data clearly
indicated the presence or absence of active DON were
considered eligible for the study. The criteria used to
diagnose DON included the following: 1) The presence of
a confirmed VF defect on SAP or GP associated or not with
diminished best-corrected VA and not caused by changes in
transparency and 2) in unilateral and asymmetric cases, the
presence of a relative pupillary defect. When the best-
corrected VA was normal and VF abnormalities were
present on SAP, a repeat examination using SAP or GP
was performed to rule out false-positive responses.
Therefore, only eyes with confirmed VF defects were
included in the analysis. Eyes with normal VA and
nonreproducible VF abnormalities on repeat examinations
were excluded. Patients with ocular or optic nerve diseases
that could interfere with the diagnosis of DON were also
excluded. All patients with DON had active disease, visual
disturbance within three months of the onset of the disease
and clinical signs of orbital congestive disease. Patients from
the group without DON had a history of orbital disease
ranging from two months to four years. The findings for the
two groups were compared.
Statistical analysis
Descriptive statistics included the mean values¡SD for
normally distributed variables. Receiver operating charac-
teristic (ROC) curves were used to describe the ability of the
VCI and the VACI to discriminate between orbits with and
without DON. For each parameter, sensitivities at the fixed
specificities of 80% and 95% were calculated. Sensitivity,
specificity, likelihood ratio, and accuracy were calculated
for the best cutoff values of VCI and VACI. The intraclass
Figure 1 - A, B and C. Examples of the area outlined on 3 axial slices of computed tomography scans, from which measurements were
obtained. Representation of the soft tissue (mostly muscles; D) and orbital fat (E) volumes based on measurements of the sequential
axial slices.
Figure 2 - Percentage difference from rest to ventilatory
anaerobic threshold (rest/VAT), rest to respiratory compensation
point (rest/RCP) and rest to peak of exercise (rest/Peak) in
patients with coronary artery disease subjected to continuous
exercise training (panel A) and interval exercise training (panel
B). VAT= ventilatory anaerobic threshold; RCP= respiratory com-
pensation point. * p,0.05 vs. post-intervention.
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correlation coefficient (ICC) was calculated to assess the
interrater and intrarater variability for the VCI and VACI
measurements. A p-value less than 0.05 was considered
statistically significant.
RESULTS
Thirty-two of the 93 patients were excluded based on
theabove-described criteria. The remaining 61 patients (37
women and 24 men) had 102 orbits that were included in the
study. The orbits were divided into two groups according to
the presence or absence of DON. The first group included 41
orbits of 27 patients (12 women and 15 men; mean age¡SD:
53.8¡10.1 years) who met the diagnostic criteria for DON.
Fourteen patients had bilateral DON; for those patients, both
orbits were included in the study. Thirteen patients had only
one orbit included in the DON group. Of these 13 patients,
the contralateral eye of ten patients did not meet the DON
criteria. Two patients had the contralateral eye excluded
because the presence or absence of DON could not be clearly
determined; in one patient, a history of central retinal artery
occlusion unrelated to GO excluded the contralateral eye. The
second group included 61 orbits in which DON was clearly
absent from 34 patients (25 women and nine men; mean
age¡SD: 42.3¡10.2 years). In this group, seven orbits were
excluded from analysis because of the uncertainty of the
DON diagnosis. Six of these patients had questionable VF
abnormalities on SAP even after repeat examinations. One
patient had an eye with severe deviations caused by
extraocular muscle involvement, which precluded proper
VF examination.
For the 41 orbits with DON, the best-corrected VA was 1.0
in 20 patients, 0.9 in seven patients, 0.8 in six patients, 0.7 in
one patient, 0.6 in two patients, 0.4 in one patient, 0.5 in
two patients, 0.2 in one patient, and 0.1 in one patient.
Exophthalmometry measurements in the affected eyes
ranged from 19 to 32 mm (mean¡SD: 25.14¡3.19 mm).
Restrictive myopathy was present in all orbits with DON.
The fundoscopic examination revealed optic disc edema in
eight eyes, optic disc pallor in one and no abnormalities
in the remainder. In the group without DON, the best-
corrected VA was 1.0 in all eyes, and exophthalmometry
findings ranged from 16.0 to 31.5 mm (mean¡SD:
23.4¡2.7).
Table 1 shows the mean¡SD and the ranges for the VCI
and VACI. The mean VCI and VACI values were signifi-
cantly higher in the orbits with DON (p,0.001).
Table 2 compares the two groups’ areas under ROC
curves for the two volumetric indexes, with confidence
intervals and sensitivity at the 95% and 80% specificity rates.
The area under the ROC curve was 0.86 for the VCI and 0.92
for the VACI. Cutoff values were determined for the two
indexes to calculate their sensitivity and specificity for
differentiating orbits with and without DON. The best
sensitivity/specificity ratio was achieved with a VACI
cutoff of 4.14 (sensitivity: 90%, specificity: 87%, likelihood
ratio: 6.9, accuracy for detecting DON: 88%; Table 2).
The ICCs for the VCI and VACI as determined by the
second observer were 0.90 and 0.91, respectively (p,0.001),
indicating an excellent interobserver variability. Corres-
ponding values for repeated measurements by the same
observer were 0.90 and 0.89, indicating excellent intraob-
server variability (p,0.001).
DISCUSSION
GO can be an insidious disease, and DON is a significant
complication that requires prompt diagnosis and treatment
to prevent permanent visual damage. Although research
has suggested that DON may be caused by inflammatory
and vascular mechanisms, the most widely accepted theory
for DON development is direct compression of the optic
nerve by enlarged extra ocular muscles at the orbital apex
(3,6,23,24). The diagnosis of DON depends mainly on
clinical features based on visual function assessment,
afferent pupillary defect and fundoscopic abnormalities.
Nevertheless, DON is often subclinical and in many cases, it
is difficult to diagnose because of confounding signs and
symptoms. Furthermore, patients with severe orbitopathy
tend to have more congestive and oculomotor symptoms,
which may outweigh or mask subtle visual deterioration (6).
Therefore, the development of imaging techniques that
facilitate the diagnosis of DON is highly desirable.
Table 1 - Means¡standard deviation of the axial
volumetric orbital crowding index (VCI) and the coronal
volumetric orbital apex crowding index (VACI) in the
orbits of patients with Graves’ orbitopathy (GO) with or
without dysthyroid optic neuropathy (DON).
Parameter
Orbits with DON
n = 41
Orbits without
DON
n = 61 p-value*
Mean¡SD VCI
95% CI
Range
1.84¡1.02
1.52–2.16
0.31–5.28
0.83¡0.28
0.76–0.90
0.34–1.53
,0.001
Mean¡SD VACI
95% CI
Range
21.35¡21.09
14.69–28.01
1.03–86.52
2.82¡2.28
2.24–3.40
0.59–10.97
,0.001
*Student’s t-test. Significant values are in italics. CI = confidence interval.
Table 2 - Area under the receiver operating characteristics curves (AUC) and sensitivities at fixed specificities for the
volumetric crowding index (VCI) and the volumetric apical crowding index (VACI). Sensitivity, specificity, likelihood ratio
(LR) and accuracy are presented for the best cutoff values of VCI and VACI.
Parameter AUC (SE) Sensitivity/specificity
Cutoff
value
Sensitivity/specificity
at cutoff value
LR
(95% CI)
Accuracy
(95% CI)
Specificity
$ 95%
Specificity
$ 80%
VCI 0.86 (0.04) 56/95 71/80 1.08 71%/80% 3.6
(2.1-6.2)
76%
(67%-85%)
VACI 0.92 (0.31) 66/95 93/80 4.14 90%/87% 6.9
(3.9-10.8)
88%
(80%-93%)
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Previous CT studies have demonstrated a direct correla-
tion between orbital apex crowding by enlarged extraocular
muscles and the development of DON (6,12,13,18,24,25).
Recent studies also suggest that bony orbit anatomy may
play an important role in the development of DON because
narrow orbits are more susceptible to apex crowding (11). In
addition, other CT features (such as intracranial fat
prolapse, lacrimal gland displacement, exophthalmos sever-
ity and superior ophthalmic vein dilatation) have been
proposed but have not been confirmed as useful for
detecting DON (4,6,11,17,24,26).
Because the presence of apical crowding on CT imaging is
strongly correlated with DON in GO, several authors have
proposed indexes for detecting DON. Barret et al. (13)
calculated a linear muscle index from CT images and found
it to be reproducible and reasonably efficient for detecting
DON. In a previous study, we investigated the sensitivity
and specificity of this muscle index calculation with MDCT
and found the best combination (79% sensitivity and 72%
specificity) at a muscle index of 60% (5). Nugent et al. (14)
proposed a categorical scale for apical crowding, which was
later reproduced by many other authors (4,11,16,17). Using
this method, Nugent et al. (14) found severe apical orbital
crowding in 12 out of 18 orbits with DON, but only in 16 out
of 124 orbits without DON. While it seems clear that
crowding scores are useful for detecting DON, the accurate
use of the scores is difficult because the authors of these
studies did not provide clear definitions of the positions
along the orbit where the coronal plan was used to
determine their scores.
In our study, we attempted to improve on existing CT
indexes with a volumetric quantification of orbital crowd-
ing. In previous studies, extraocular muscle volume
estimates were useful for detecting DON, but the manual
quantitative analysis of the extraocular measurements was
time-consuming and complex (12,18,25). In our study,
orbital structures could be precisely reformatted using an
MDCT scanner, and the measurement of the orbital
structures with the volumetric analysis software was
straightforward. The technology has mainly been used in
studies to estimate the increase in orbital fat, the effect of
orbital radiotherapy or the effect of orbital decompression
on orbital structures. However, to our knowledge, no
previous study has evaluated the technology’s ability to
predict DON (19,27-31). According to published guidelines
for the radiologic measurement of tissue volumes in GO
patients, there is currently no consensus on how to measure
orbital fat and extraocular muscle volume (32). To obtain
volume measurements, we used a computer-assisted algo-
rithm based on the density of soft tissue and orbital fat. We
then calculated the following two volumetric indexes: the
VCI, which is the ratio of the extraocular muscle volume to
the orbital fat volume and is based on axial scans of the
entire orbit; and the VACI, which is the ratio of the
extraocular muscle volume to the orbital fat volume and is
based on coronal scans of the orbital apex. The indexes
appeared to be reliable and reproducible, as suggested by
the high ICC values found in this study.
In our study, all patients were carefully and prospectively
evaluated for the presence or absence of DON, and a large
number of orbits with optic neuropathy were included. Both
indexes were efficient at differentiating patients with DON
from patients without DON. The VACI, which evaluates
the orbital apex, was particularly effective; it achieved a
sensitivity of 90% and a specificity of 87% at a cutoff of 4.14,
whereas the VCI achieved only 71% sensitivity and 80%
specificity at a cutoff of 1.08. These findings indicate that
volumetric orbital crowding measurements are better at
detecting DON in patients with GO when they are restricted
to the orbital apex.
Our analysis of the performance of the VACI indicates a
significant improvement over previous indexes in identify-
ing patients with DON. The VACI was more efficient than
Figure 3 - A, B and C. Examples of the area outlined on 3 coronal slices of computed tomography scans, fromwhich measurements were
obtained. Representation of the soft tissue (mostly muscles) (D) and orbital fat (E) apical volumes based on sequential coronal orbital
slices.
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both the Nugent scale, which was evaluated in several
previous studies (4,14,16,17), and the linear muscle index
described by Barret et al. (13). The latter suggested that an
index of 67% or greater would have a diagnostic sensitivity
of 67% for detecting DON (13). In a previous study that
investigated the sensitivity and specificity of this muscle
index using MDCT, the best sensitivity/specificity combi-
nation (79%/72%) was observed at a muscle index of 60%
(5). This is clearly inferior to the performance of the indexes
tested in the current study.
In conclusion, our study tested the value of two
volumetric indexes for assessing the degree of apical
crowding, one based on measurements of the entire orbit
and one based on measurements of the orbital apex only.
Both indexes were found to be efficient at predicting DON,
although the latter index was more effective. Further studies
are necessary to validate our findings.
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